ALCAM and malignant colon neoplasm: It is reported that suppression of sp1 expression reduced the growth of colon cancer stem cells (CCSC) and induced apoptosis in vitro and in nude mouse xenografts, and the proportion of CCSC markers, CD44+/CD166+, was decreased following sp1 knock-down [34].